期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (4)
It has been established that Cutaneous T-Cell lymphomas (CTCL) are caused by the monoclonal proliferation of T lymphocytes in the skin. This heterogen......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (4)
Autologous hematopoietic stem cell transplantation (ASCT) and chimeric antigen receptor T-cell therapy (CART) are salvage therapies that are utilised ......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (4)
Treatment for relapsed/refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) is evolving rapidly due to the emergence of novel drugs, of which histone ......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (2)
To evaluate the outcome and prognostic significance of CEBPA mutations among pediatric acute myeloid leukemia (AML) from TARGET dataset. A total of 18......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (2)
Exosomal microRNAs (miRNAs) are potential biomarkers for a variety of tumors, but have not yet been studied in diffuse large B-cell lymphoma (DLBCL). ......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (5)
Natural killer (NK)/T cell lymphoma is a highly aggressive subtype of non-Hodgkin lymphoma. The prognosis of patients with natural killer T cell lymph......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (4)
Acute graft-versus-host disease (aGVHD) causes significant morbidity and mortality. While most studies focus on classic or late aGVHD, some patients w......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (3)
Concurrent translocations of MYC and BCL2 lead to abnormal expression of both oncoproteins, which contribute to the aggressive clinical characteristic......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (5)
This study compared the efficacy, safety and immunogenicity of ripertamab (SCT400) and rituximab (Mabthera (R)) combined with CHOP as the first-line t......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (1)
Prolonged isolated thrombocytopenia (PIT) is a common complication after umbilical cord blood transplantation (UCBT). However, data on PIT prediction ......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (5)
Aberrant activity of histone deacetylases (HDACs) is frequently detected in B-cell lymphomas, which indicated the therapeutic implications of HDAC inh......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (3)
The mantle cell lymphoma (MCL) International Prognostic Index (MIPI) and combined MIPI (MIPI-c) are commonly used for risk classification of MCL patie......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (4)
Although several studies have investigated the benefits of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for patients with inv (16) a......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (5)
In chronic myeloid leukemia (CML) patients, the involvement of the BCR/ABL1 isoform in tyrosine kinase inhibitors (TKIs) resistance has attracted lots......
期刊： HEMATOLOGICAL ONCOLOGY, 2022; 40 (5)
Diffuse large B-cell lymphoma (DLBCL) is a group of heterogeneous tumors with different molecular traits and clinical features. MYD88 is an oncogene t......
